$SRNE News Article - Sorrento Therapeutics Announc
Post# of 114
(Total Views: 247)
Posted On: 06/03/2022 3:35:53 PM
$SRNE News Article - Sorrento Therapeutics Announces First Subject Dosed in a Phase I Clinical Study of STI-1558, an Oral Mpro Inhibitor as a Standalone Treatment and Prevention of COVID-19 Without Co-Administration of Ritonavir Booster https://marketwirenews.com/news-releases/sorr...94693.html
(0)
(0)Sorrento Therapeutics Inc. (SRNE) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼